Safety and Tolerability of Anti–microRNA-328 Ophthalmic Solution, SHJ002, in Pediatric Subjects: First-in-Human Clinical Study - Chen, Jiunn-Liang; Lai, Wei-Yu; Lin, Reuy-Tay; Juo, Suh-Hang H.; Liang, Chung-Ling (Clinical therapeutics, 2024)
Keywords: Antisense therapy; Childrens health; Clinical outcomes; Clinical trials; Drug dosages; Eye; FDA approval; First-in-human; Genes; Health care; Health risks; Internal Medicine; Keratitis; MicroRNA-328; MicroRNAs; miRNA; Missing data; Myopia; Oligonucleotide; Pediatrics; Risk factors; United States--US; Oligonucleotide; MicroRNA-328; First-in-human; Myopia